Happy Thanksgiving! Save 50% on Your MarketBeat All Access Subscription.
Special Offer: Just $199
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
See how to make money instead of spending it on Black Friday with this offer (Ad)
Saudi viewers angry over apparent ban on World Cup streaming
Walmart shooting claims teen, young woman, father, mother
THE BEST BLACK FRIDAY DEAL YET (Ad)
Cuba's informal market finds new space on growing internet
Best Buy Proves Brick and Mortar is Here to Stay
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
See how to make money instead of spending it on Black Friday with this offer (Ad)
Saudi viewers angry over apparent ban on World Cup streaming
Walmart shooting claims teen, young woman, father, mother
THE BEST BLACK FRIDAY DEAL YET (Ad)
Cuba's informal market finds new space on growing internet
Best Buy Proves Brick and Mortar is Here to Stay
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
See how to make money instead of spending it on Black Friday with this offer (Ad)
Saudi viewers angry over apparent ban on World Cup streaming
Walmart shooting claims teen, young woman, father, mother
THE BEST BLACK FRIDAY DEAL YET (Ad)
Cuba's informal market finds new space on growing internet
Best Buy Proves Brick and Mortar is Here to Stay
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
See how to make money instead of spending it on Black Friday with this offer (Ad)
Saudi viewers angry over apparent ban on World Cup streaming
Walmart shooting claims teen, young woman, father, mother
THE BEST BLACK FRIDAY DEAL YET (Ad)
Cuba's informal market finds new space on growing internet
Best Buy Proves Brick and Mortar is Here to Stay
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
NASDAQ:PMD

Psychemedics - PMD Stock Forecast, Price & News

$5.83
+0.09 (+1.57%)
(As of 11/25/2022 08:58 PM ET)
Add
Compare
Today's Range
$5.83
▼
$5.93
50-Day Range
$5.73
▼
$6.66
52-Week Range
$5.73
▼
$8.46
Volume
700 shs
Average Volume
10,475 shs
Market Capitalization
$32.91 million
P/E Ratio
N/A
Dividend Yield
4.80%
Price Target
N/A
PMD stock logo

About Psychemedics (NASDAQ:PMD) Stock

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine and Fentanyl. Its testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. The company offers its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts.

Receive PMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Psychemedics and its competitors with MarketBeat's FREE daily newsletter.

PMD Stock News Headlines

November 12, 2022 | finance.yahoo.com
Psychemedics Third Quarter 2022 Earnings: US$0.02 loss per share (vs US$0.13 profit in 3Q 2021)
November 9, 2022 | finance.yahoo.com
Psychemedics Corporation Reports Third Quarter 2022 Financial Results and Declares Quarterly Cash Dividend
November 28, 2022 | Legacy Research (Affiliate) (Ad)
THE BEST BLACK FRIDAY DEAL YET
This Black Friday, you can save 95% off of a 1-year membership to Brad Thomas’s Intelligent Income Investor. This service is geared toward helping you collect the safest dividend income in the market. It all starts with Brad’s “SWAN” portfolio, of the 10 best companies to own through any market.
November 7, 2022 | finance.yahoo.com
One Psychemedics Corporation (NASDAQ:PMD) insider upped their stake by 13% in the previous year
October 4, 2022 | reuters.com
PMD.O - Psychemedics Corp. | Stock Price & Latest News | Reuters
September 8, 2022 | reuters.com
PMD.OQ - Psychemedics Corp. | Stock Price & Latest News | Reuters
August 19, 2022 | nasdaq.com
Don't Buy Psychemedics Corporation (NASDAQ:PMD) For Its Next Dividend Without Doing These Checks - Nasdaq
August 18, 2022 | finance.yahoo.com
Don't Race Out To Buy Psychemedics Corporation (NASDAQ:PMD) Just Because It's Going Ex-Dividend
November 28, 2022 | Legacy Research (Affiliate) (Ad)
See how to make money instead of spending it on Black Friday with this offer
Ph.D. Economist and Investor Nomi Prins is releasing details on her next stunning prediction… It involves “liquid energy” that is promising to trigger an energy revolution 117x bigger than all of the hottest tech trends combined. Even the world’s richest billionaires are investing in the tiny company behind it. And today, you can get in on this cutting-edge financial research at an incredible price tailor-made for Black Friday.
August 11, 2022 | streetinsider.com
Form 10-Q PSYCHEMEDICS CORP For: Jun 30 - StreetInsider.com
August 9, 2022 | greenwichtime.com
Psychemedics: Q2 Earnings Snapshot - Greenwich Time
August 9, 2022 | finance.yahoo.com
Psychemedics Corporation Reports Second Quarter 2022 Financial Results and Declares Quarterly Cash Dividend
August 9, 2022 | globenewswire.com
Psychemedics Corporation Reports Second Quarter 2022 Financial Results and Declares Quarterly Cash Dividend - GlobeNewswire
July 18, 2022 | nz.finance.yahoo.com
Eliem Announces Updated Development Plans and the Advancement of ETX-155 for the Treatment of Major Depressive Disorder
July 6, 2022 | streetinsider.com
Form DEF 14A PSYCHEMEDICS CORP For: Aug 12 - StreetInsider.com
June 16, 2022 | globenewswire.com
Global Drug Screening Laboratory Services Market (2022 to 2027) - Technological Advancements to Improve the Accuracy of Drug Screening Presents Opportunities - GlobeNewswire
June 16, 2022 | finance.yahoo.com
Insights on the Drug Screening Laboratory Services Global Market to 2027 - Featuring MPD, Omega Laboratories and Orasure Technologies Among Others - Yahoo Finance
June 16, 2022 | finance.yahoo.com
Global Drug Screening Laboratory Services Market (2022 to 2027) - Technological Advancements to Improve the Accuracy of Drug Screening Presents Opportunities - Yahoo Finance
June 15, 2022 | businesswire.com
The Worldwide Drug Screening Laboratory Services Industry is Projected to Reach $13.6 Billion by 2027 - ResearchAndMarkets.com - Business Wire
June 10, 2022 | finance.yahoo.com
Psychemedics Announces Two New Director Nominees for its 2022 Annual Meeting of Stockholders and Director Walter S. Tomenson, Jr.’s Retirement after More than 20 Years of Dedicated Service - Yahoo Finance
June 9, 2022 | globenewswire.com
Psychemedics Announces Two New Director Nominees for its 2022 Annual Meeting of Stockholders and Director Walter S. Tomenson, Jr.'s Retirement after More than 20 Years of Dedicated Service - GlobeNewswire
June 9, 2022 | finance.yahoo.com
Psychemedics Announces Two New Director Nominees for its 2022 Annual Meeting of Stockholders and Director Walter S. Tomenson, Jr.’s Retirement after More than 20 Years of Dedicated Service
June 7, 2022 | finance.yahoo.com
Capital Allocation Trends At Psychemedics (NASDAQ:PMD) Aren't Ideal
May 17, 2022 | globenewswire.com
Global Drug Screening Market to Witness Steady Expansion Growth of USD 25.12 billion by 2027 : Fior Markets - GlobeNewswire
May 11, 2022 | nasdaq.com
Daily Dividend Report: PSX,PMD,MMM,PRU,DHR - Nasdaq
May 10, 2022 | seekingalpha.com
Psychemedics raises dividend by 40% to $0.07 - Seeking Alpha
May 10, 2022 | globenewswire.com
Psychemedics Corporation Reports First Quarter 2022 Financial Results and Declares Increased Cash Dividend - GlobeNewswire
See More Headlines
Receive PMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Psychemedics and its competitors with MarketBeat's FREE daily newsletter.

PMD Company Calendar

Last Earnings
4/23/2019
Ex-Dividend for 9/9 Dividend
8/23/2022
Dividend Payable
9/09/2022
Today
11/28/2022
Ex-Dividend for 12/16 Dividend
12/01/2022
Dividend Payable
12/16/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
4/04/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PMD
CUSIP
N/A
CIK
806517
Web
www.psychemedics.com
Phone
(978) 206-8220
Fax
978-264-9236
Employees
139
Year Founded
1985

Profitability

EPS (Most Recent Fiscal Year)
($0.36)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-670,000.00
Net Margins
-7.77%
Pretax Margin
-10.53%
Return on Equity
-16.68%
Return on Assets
-9.67%

Debt

Debt-to-Equity Ratio
0.03
Current Ratio
1.74
Quick Ratio
1.74

Sales & Book Value

Annual Sales
$24.91 million
Price / Sales
1.32
Cash Flow
$0.55 per share
Price / Cash Flow
10.68
Book Value
$2.21 per share
Price / Book
2.64

Miscellaneous

Outstanding Shares
5,645,000
Free Float
4,894,000
Market Cap
$32.91 million
Optionable
Not Optionable
Beta
0.53

Social Links


Key Executives

  • Mr. Raymond C. Kubacki (Age 77)
    Chairman, CEO & Pres
    Comp: $473.2k
  • Mr. Charles M. Doucot IV (Age 56)
    Exec. VP
    Comp: $262.75k
  • Dr. Michael I. Schaffer Ph.D. (Age 77)
    VP of Laboratory Operations
    Comp: $248.02k
  • Dr. Werner A. Baumgartner Ph.D.
    Founder
  • Ms. Annette Baumgartner
    Founder
  • Ms. Sarah Ashby
    VP & Gen. Counsel
  • Mr. Patrick J. Kinney Jr.
    Sec.

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













PMD Stock - Frequently Asked Questions

How have PMD shares performed in 2022?

Psychemedics' stock was trading at $7.02 on January 1st, 2022. Since then, PMD stock has decreased by 17.0% and is now trading at $5.83.
View the best growth stocks for 2022 here.

When is Psychemedics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 4th 2023.
View our PMD earnings forecast.

How were Psychemedics' earnings last quarter?

Psychemedics Co. (NASDAQ:PMD) posted its earnings results on Tuesday, April, 23rd. The company reported $0.11 earnings per share (EPS) for the quarter. The company earned $9.82 million during the quarter. Psychemedics had a negative trailing twelve-month return on equity of 16.68% and a negative net margin of 7.77%.

How often does Psychemedics pay dividends? What is the dividend yield for Psychemedics?

Psychemedics announced a quarterly dividend on Wednesday, November 9th. Shareholders of record on Friday, December 2nd will be given a dividend of $0.07 per share on Friday, December 16th. This represents a $0.28 dividend on an annualized basis and a yield of 4.80%. The ex-dividend date is Thursday, December 1st.
Read our dividend analysis for PMD.

Is Psychemedics a good dividend stock?

Psychemedics (NASDAQ:PMD) pays an annual dividend of $0.28 per share and currently has a dividend yield of 4.80%. PMD has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for PMD.

What is Raymond C. Kubacki Jr.'s approval rating as Psychemedics' CEO?

6 employees have rated Psychemedics Chief Executive Officer Raymond C. Kubacki Jr. on Glassdoor.com. Raymond C. Kubacki Jr. has an approval rating of 67% among the company's employees.

What other stocks do shareholders of Psychemedics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Psychemedics investors own include Zynerba Pharmaceuticals (ZYNE), Dominion Energy (D), Sorrento Therapeutics (SRNE), AT&T (T), AbbVie (ABBV), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Pattern Energy Group (PEGI) and Simon Property Group (SPG).

What is Psychemedics' stock symbol?

Psychemedics trades on the NASDAQ under the ticker symbol "PMD."

Who are Psychemedics' major shareholders?

Psychemedics' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (5.44%) and Wedbush Securities Inc. (0.35%). Insiders that own company stock include Fred J Weinert, Michael I Schaffer, Peter Kamin and Raymond C Kubacki Jr.
View institutional ownership trends.

How do I buy shares of Psychemedics?

Shares of PMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Psychemedics' stock price today?

One share of PMD stock can currently be purchased for approximately $5.83.

How much money does Psychemedics make?

Psychemedics (NASDAQ:PMD) has a market capitalization of $32.88 million and generates $24.91 million in revenue each year. The company earns $-670,000.00 in net income (profit) each year or ($0.36) on an earnings per share basis.

How many employees does Psychemedics have?

The company employs 139 workers across the globe.

How can I contact Psychemedics?

Psychemedics' mailing address is 289 GREAT ROAD Suite 200, ACTON MA, 01720. The official website for the company is www.psychemedics.com. The company can be reached via phone at (978) 206-8220 or via fax at 978-264-9236.

This page (NASDAQ:PMD) was last updated on 11/28/2022 by MarketBeat.com Staff